Transcept Pharmaceuticals says it's resubmitted a New Drug Application for Intermezzo to the...

|By:, SA News Editor

Transcept Pharmaceuticals says it's resubmitted a New Drug Application for Intermezzo to the FDA. The resubmission follows a meeting between Transcept and the FDA on September 14 to discuss issues raised by the FDA in the July 2011 Complete Response Letter. Shares +3.8% AH.